The MAGE-A3 protein can act as a tumor antigen, presented by mature DCs, which can stimulate the maturation of CD8+ cytotoxic T lymphocytes (CTLs) specific for MAGE-A3. This evidence concerns the gene MAGEA3 and neoplasm.